SYBX — Synlogic, Inc.
$1.10
+$0.00 (+0.00%)
Synlogic, Inc. does not have significant operations. It was previously engaged in the discovery and development of synthetic biotics to treat metabolic diseases.
Market Cap
$13.47M
Forward P/E
-2.3x
52-Week Range
N/A
SYBX Price History
Revenue vs. Net Income
$8K
Revenue · FY2024
Annual. Net margin is shown under each year.
Free Cash Flow
-$31.7M
FCF · FY2024
Annual. FCF margin is shown under each year.
Return on Capital Employed (ROCE)
-123.7%
ROCE · FY2024
Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.
Total Assets vs. Total Liabilities
2.8x
Assets ÷ liabilities · FY2024
Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.
CapEx as % of Revenue
175.0%
CapEx · FY2024
Annual. Green at or under the 5% maximum target, red above it.
Shares Outstanding
+87.6%
Dilution · FY2024
Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).
